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Summary 
We present evidence that a single T cell clone can recognize at least five different overlapping 
peptides, each with its distinct core structure, in the context of the same major histocompatibility 
complex (MHC) molecule. Distinct core residues are crucial for triggering the T cell receptor 
(TCR) in each case. These results suggest that the TCR (a) has multiple sets of contact residues 
for alternative peptide-MHC ligands, the binding to any one of which can trigger the cell; and/or 
(b) is able to attach to the peptide-MHC complex in more than one orientation. In this sense, 
the TCR is a multisubsite  structure capable of being stimulated by a variety of peptide ligands 
associated with the same MHC molecules. 
T 
CRs recognize an antigen only when the antigen's pep- 
tide fragments are lodged in a groovelike site on MHC 
molecules  (1). How do the TCRs  interact  with the pep- 
tide-MHC complex?  The answer is not clear because the 
crystal structure of the TCR-peptide-MHC complex still has 
not been solved. In the meantime, several models for the ter- 
nary molecular interaction have been proposed in which the 
CDR3 loops (encoded by the V-(D)-J junctional region) of 
both chains of the TCR molecule bind the nominal peptide, 
whereas the germline-encoded CDR1 and CDR2 loops bind 
the oe helices of the MHC molecule, which flank its peptide- 
binding groove (1-4). 
Using variants of each of the three participating molecules 
of the TCR-peptide-MHC complex, extensive attempts have 
been made to test these predictions  (4-9).  The results from 
these studies have neither entirely supported nor contradicted 
these models; nevertheless, several characteristics of the in- 
teracting trimolecular complex have emerged. It thus seems 
clear that a single peptide-MHC ligand can induce several 
distinct  TCR molecules, with each TCR molecule recog- 
nizing a distinct aspect of the peptide in the MHC groove. 
Different TCR molecules displaying specificity for the same 
peptide-MHC ligand may interact with different and over- 
lapping  residues of the peptide  (4-8).  In addition,  studies 
with MHC mutants at the residues pointing inward along 
the wall of the peptide-binding groove of the MHC mole- 
cule showed that different TCRs displaying  identical specificity 
for the ligand were differentially  affected  by such mutant MHC 
molecules (8). These results emphasize that alterations of the 
particular conformation of the peptide-MHC complex, in- 
duced by the association  of the peptide with the altered  peptide- 
binding groove, can result in loss of recognition. Taken to- 
gether, these results indicate strict constraints in interactions 
between the TCR molecule and the peptide-MHC complex. 
However, how precise  are the requirements for peptide struc- 
ture, distribution of charge and hydrophobicity  for a peptide 
to be a stimulatory one for a given TCR? Can only a single 
sequence  from the antigen associated  with a given MHC mol- 
ecule meet the constraints of  TCR recognition? We have asked 
this question by using a previously reported panel of I-A  a- 
restricted  sperm  whale  myoglobin (SWM) 1 peptide  110- 
121-specific T cell hybridomas (10, 11). The approach used 
was to truncate this determinant from one end so as to abro- 
gate T cell recognition but to retain MHC binding, extend 
the determinant at the other end, and then examine muta- 
tions in the new peptide that could restore TCR recognition. 
We now report T hybrid CJM4-16 (from the above men- 
tioned panel of T hybrids) could be stimulated by five different 
peptides presented by I-A  d. Different core residues are cru- 
cial for triggering the TCR in each case. These results were 
obtained by (a) using a set of 180 unique peptides derived 
by substituting every residue, one by one, in the truncated 
and extended peptide 105-116 with 15 other amino acids; and 
(b) further analysis of the core structure of three of the six 
stimulatory mutants of peptide 105-116. Our findings have 
important implications for models of TCR interaction with 
peptide-MHC ligands, and they suggest that the TCR is a 
multisubsite  structure capable of being stimulated by a va- 
riety of peptide ligands presented by the same MHC molecule. 
1 Abbreviation used in this paper: SWM, sperm whale myoglobin. 
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Mice 
Mice were obtained from The Jackson Laboratory (Bar Harbor, 
ME). 
Antigens and Peptides 
SWM was obtained from Accurate Chemicals & Scientific Corp. 
(Westbury, NY). SWM peptides 110-121, 105-118, and 105-116 were 
synthesized and HPLC purified, as described previously (10-12). 
SWM peptide 105-116 and all series of mutant peptides were syn- 
thesized on polyethylene pins followed by cleavage into 96-weU plates 
(10-12). Bulk SWM peptide 105-116 and variants D109, Vl12, II14, 
and Ll14 were synthesized on pins,  as well as by conventional 
methods by Cambridge Research Biochemicals, Inc. (Wilmington, 
DE). The G107,  G108,  and Pl13 variant peptides  used to define 
the cores of these mutants (see Fig.  3) were synthesized in bulk 
(5 rag) on the pins. Mass spectroscopic analysis done on 16 of the 
24 peptides used in Fig.  3 showed the expected molecular mass 
and 15 of the 16 peptides consisted of a single product. OVA pep- 
tide 323-339  was  synthesized as described earlier  (13). 
Generation of T  Cell Hybrids 
The cloned T cell hybridoma CJM4-16 was derived from con- 
tinuously growing SWM peptide 110-121-specific T cell lines, as 
described previously (10, 11). Briefly, T  cell blasts  from antigen- 
specific cell lines were fused with the ~-fl-  variant of BW5147 
as a fusion partner and cloned by limiting dilution in the presence 
of SWM or its peptides,  110-121, and 105-118 (10, 11). The antigen- 
reactive hybrids were analyzed for function and TCK V~ expres- 
sion. The hybrid CJM4-16 was further subcloned by limiting dilu- 
tion and analysis for antigen specificity. 
Specificity Assays 
T Cell Hybrids.  T  hybridoma cells (5  x  104) were cultured 
with various  concentrations of a given peptide with 5  x  10  s ir- 
radiated BALB/c (I-A  a, I-E  d) spleen calls as APCs in 0.2 ml sup- 
plemented DMEM (Ftow Laboratories, Ayrshire, Scotland). All cub 
tures were done in triplicate, except those with the 180 variants 
of peptide 105-116, which were done in single  wells for a given 
dose of peptide in each experiment. The culture supematants col- 
lected 24 h later were assayed for IL-2 activity with the Ib2/Ib 
4-dependent cell line, HT-2, as described earlier (10, 11). Briefly, 
104 HT-2 cells were cultured with medium alone or with super- 
natants for 48 h, and proliferation was measured by adding 1 #Ci 
[3H]thymidine during the last  18 h of culture, and incorporation 
was assayed by liquid scintillation counting. Peptides  110-121 and 
105-118 (synthesized by conventional methods) were used as posi- 
tive control peptides in all experiments. In our previous extensive 
use of peptides synthesized on pins, we (reference 11; Sercarz, E., 
unpublished observations) have not experienced cases of false nega- 
tives or positives in comparison to conventionally synthesized pep- 
tides. Negative results with certain peptides and particular hybrids 
have been matched by positive results with other T  cells. 
Binding of Peptides to 1-/t  d 
I-A  d was  affinity purified from cell lysates of A20 lymphoma 
cells using anti-I-A  a mAb MKD-6 (13). OVA peptide 323-339 was 
radiolabeled with 12sI using the chloramine T  method. Peptides 
were tested for binding to ]-A  d as measured by their capacity to 
inhibit the binding of *2SI-radiolabeled OVA peptide 323-339, as 
described previously (13). 
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Results 
Panels of I-Aa-restricted SWM peptide 110-121-specific T 
call hybridomas (10, 11) have been reported previously. The 
minimal core of the peptide determinant recognized by this 
panel of T hybrids includes amino acids 110-118.  The "core" 
of a peptide determinant is defined as the minimal residues 
required for both (a) binding to MHC molecules and (b) in- 
teracting with the TCR molecule (11). By removing the two 
amino acids essential for interaction with the TCR from the 
minimal core, we generated a truncated-core peptide that could 
still bind the MHC molecule but not stimulate the T  cell 
population.  SWM peptide 105-116 is such a truncated-core 
peptide for T  cell hybrids that recognize SWM peptide 110- 
121, where the original stimulating core is peptide 110-118. 
Pet,  tide 105-116 Binds to the I-A a Molecule but Fails to 
Stimulate SWM Peptide 110-121-specific T  Cells 
Fig. 1 shows dose-response curves for activation of CJM4-16 
by peptides  105-116 and  110-121  (the peptide antigen used 
to derive these T cell hybrids), and it shows that peptide 105- 
116 was nonstimulatory, even at a concentration of 70 #M. 
As shown in Table 1,  in a direct binding assay to purified 
I-A  d, peptide 105-116 could bind to I-A  a better (threefold, 
see the legend of Table 1) than peptide 110-121 (Table 1). That 
the failure of peptide  105-116 to stimulate CJM4-16 was a 
result  of the absence of core TCK-interactive residues  117 
and  118 and not of negative influences (14) exerted by the 
extra NH2-terminal sequence 105-109 was demonstrated by 
the fact that peptide 105-118 was found to be highly stimula- 
tory (Fig.  1). 
Six Mutants  of the Truncated-core Peptide 105-116 are 
Stimulatory  to T  Hybrid  CJM4-16  and Subclone CJM4-16-4 
In the next series of experiments, every amino acid within 
peptide 105-116 was substituted,  one by one, with 15 alter- 
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Figure  1.  Peptide  105-116 does not stimulate T hybridoma CJM4-16 
specific for peptide 110-121 of SWM. CJM4-16 T hybridoma cells (5  ￿ 
104) were cultured with various concentrations of the peptides 110-121 
(0-0),  105-116 (I-m), and 105-118 (O-C]) with 5  x  10  s irradiated 
BALB/c spleen  cells as APCs (10, 11). AU cultures were performed  in tripLi- 
cate in 0.2 ml. Supernatants from these cultures were then used to assay 
proliferation of HT-2 cells as described before (10, 11) and in Materials 
and Methods, and the data are expressed  as means + SE of each triplicate 
culture. The mean _+ SE value for medium controls for this experiment 
was 1.09 _+ 0.37 (x10-3). 
T Cell Receptor Recognizes Multiple Peptide Cores Table  1A.  Binding to MHC I-A a Versus Stimulation of T Hybrid CJM4-16-4 by Peptide 105-116 and its Stimulatory Mutants 
Relative binding  Stimulation 
Peptide  Sequence  to MHC*  of CJM4-16" 
105-116  EFISEAIIHVLH  1.5  - 
-G107  __G  0.34  +  +  + 
-G108  G  0.1  +  +  + 
-Pl13  p  1.8  +  +  + 
-Ll14  L  0.18  +  +  + 
-II14  I_  0.01  +  +  + 
110-121  .SKHPG  0.59  +  +  + 
Table  lB.  Binding of Peptides Constituting the First Peak of the I05-116-G108 Series of Peptides to MHC I-Aa: Strength of 
Stimulation is not Directly Related to Strength of MHC Binding 
Relative binding  Stimulation 
G108  analogues  Sequence  to MHC*  of CJM4-16" 
101-112  IKYLEFIGEAII  0.003  + / - 
102-113~  KYLEFIGEAIIH  0.011  +  +  + 
103-114  YLEFIGEAIIHV  0.040  + 
104-115  LEFIGEAIIHVL  0.013  +  + 
* The binding capacity of each peptide is expressed relative to I-A  a binding of unlabeled OVA Peptide 323-339 (13). The 50% inhibition value for 
unlabeled OVA peptide 323-339 was 131  _+ 34 nm in the experiments considered. The values shown in the Table are means of at least two indepen- 
dent experiments. The quantitative values for stimulation are shown in Fig. 2 for Table 1 A and Fig. 3 for Table 1 B. The stimulation of CJM4-16 
is depicted as  + + +  when proliferation of HT-2 cell is 15-fold or more than the background (medium control),  + +  when it is between  5-10 
times the background,  +  when it is 3-5 times the background,  and  +/-  when proliferation is 2-3 times the background. 
The first peak of G-108 mutants. 
native amino acids,  thus  creating  180 unique  peptides.  Re- 
sponse to the  180 peptides was examined for cloned T  hy- 
hridoma CJM4-16  (core:  110-118)  and its subclone,  CJM4- 
16-4, to ensure that all responses were definitively caused by 
a single T  cell. The results from a representative of three ex- 
periments for T  hybrid CJM4-16-4,  at the optimal peptide 
concentration (7 #M) are shown in Fig. 2 A  and were nearly 
identical to those obtained with CJM4-16 (data not shown). 
Surprisingly, it was found that several singly substituted ana- 
logues of truncated-core  peptide  105-116  could  trigger the 
SWM peptide 110-121-specific T  hybridoma CJM4-16 or its 
subclone and this pattern of stimulation was repeated in each 
experiment studied at three peptide concentrations (see legend 
of Fig.  2 A). 
Fig. 2 B  shows the dose-response curves for five stimula- 
tory mutants and one nonstimulatory analogue (Ql10) of pep- 
tide 105-116 over a large range (0.1-70 #M) of peptide con- 
centrations. It is clear that the nonstimulatory mutant peptide 
does not stimulate even at a 70-#M concentration of peptide. 
The six singly substituted mutants of peptide 105-116 that 
were strongly  stimulatory  in all the experiments  could be 
divided  into  two  categories: 
Replacements Outside the Minimal Determinant Core (110-118) 
that Convert the  Truncated-core Peptide 105-116 into a Stimula- 
tory Fragment.  (a) 1-107 to G-107, (b) S-108 to G-108, and 
(c) E-109 to D-109 or G-109 can convert the inactive peptide 
105-116  into  a  highly  stimulatory  peptide. 
Replacements within the Original Core Residues That Also Con- 
vert the  Truncated-core Peptide 105-I16 into a Stimulatory Pep- 
tide.  (d) H-113 to P-113, (e) V-114 to 1-114, or (f) to L-114. 
Note that several other clones within our panel of SWM ll0- 
121-specific  CD4 T  hybrids  recognized  a different  pattern 
of mutant peptides, while certain other T  hybrids were not 
stimulated  by any of the  variants  of peptide  105-116  (data 
not  shown). 
Stimulatory  Variants of Peptide 105-116 Bind to Ill a Within 
the Same Range as the Nonstimulatory 105-116 
Table 1 A  shows that the stimulatory mutants of peptide 
105-116, as well as SWM 110-121, display a relative binding 
to  purified  I-A  a  in  a  comparable  range  (range  of relative 
binding  =  0.1-1.8,  see legend of Table 1) with the exception 
of peptide 105-116-[Ii14], which shows low binding to I-A  d 
but can nevertheless stimulate T  hybrid CJM4-16 very well 
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CJM4-16-4  :  105-116 VARIANTS 
between the ability of a peptide to bind the MHC molecule 
and to activate a T cell. The nonstimulatory peptide 105-116 
is one of the best binders to I-A  a, binding about threefold 
better  than  the  original  immunogen,  SWM  110-121  (see 
Table 1). 
Analysis of the Core Structure of the Stimulatory Mutants 
of p105-116 
Three of six stimulatory mutants of the nonstimulatory 
peptide  105-116 were selected to analyze the core structure 
recognized  within  the  mutant  peptides.  The  core  regions 
within the G-107, G-108,  and P-113 mutant peptides were 
studied by using three series of 12-mer peptides, sequentially 
traversing the sequence 100-118 with G always always at po- 
sition 107 or 108, respectively, or spanning region 102-120, 
with  P  at positions  113  (see Fig.  4). 
The results depicted for T hybrid CJM4-16-4 (Fig. 3) clearly 
show a surprising "dual-core" pattern of response within each 
of the three series of overlapping mutant peptides that were 
tested (Fig. 3). Thus hybridoma CJM4-16-4 optimally recog- 
nizes two core structures in both mutant peptides G-107 and 
G-108:  (a) 102-113 and (b)  105-116.  It is not clear whether 
or not this dual-core pattern within this sequence is a result 
of hindrance or facilitation in presentation of the peptide by 
the MHC molecule as one moves along the frame of the pep- 
tide.  Table  1  B  shows  the  binding  to  I-A  d of  peptides 
defining  the  NH2-terminal  core  102-114-[G108],  and it  is 
clear  that the dual-core pattern of response is not a direct 
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Figure 2.  (.4) Several of the 180 mutants of the nonstimulatory, trun- 
cated core peptide 105-116 regain antigenicity for T  hybridoma CJM4- 
16-4. Every amino acid within peptide 105-116 (EFISEAIIHVLH) was sub- 
stituted, one by one, with 15 alternative amino acids, thus creating 180 
unique peptides. One representative  of three experiments is depicted at 
the optimal dose of 7 #M peptide. The vertical axis refers to proliferation 
with the peptide minus that obtained with the medium alone control. 
Proliferation was assayed as in Fig. 1. The horizontal axis refers to the 
substituted amino acid in the single letter code. At the top of each panel 
is shown the native amino acid and its specific position in peptide 105-116. 
The 14- and 3.5-#M doses of peptides gave results similar (data not shown) 
to the 7-/zM dose of peptide. The mean  _+  SE values of triplicates for 
medium, peptides 105-116, and SWM peptide 110-121 in this experiment 
were 0.33  _+  0.005  (x10-3), 0.69  _+ 0.005  x  (10-3), and 29.7  _+  3.5  x (10-3).  The stimulatory potential of four mutant peptides (105-116- 
[O109],  105-116-[1112], 105-116-[1114], and 105-116-[Ll14]), synthesized 
by conventional methods (10, 11), was not different from that shown by 
peptides synthesized by the pin methodology (data not shown; references 
11, 31). All the stimulatory analogues, when tested using B10.GD (I-E-) 
spleen cells as APCs, showed the same results (data not shown) as with 
BALB/c (bEd+) APCs. Thus as with the original immunogen, peptide 
110-121, responses with the stimuhtory analogues were restricted to I-A  d. 
(/3) The stimulatory and nonstimulatory mutant peptides show a consistent 
pattern over a large concentration range.  Shown is the stimulation of 
T hybrid CJM4-16-4  with five stimulatory analogues of peptide 105-116 
(G107, G108, Pl13, II14, and Ll14) and one nonstimulatory analogue (Ql10) 
of peptide 105-116 at a concentration range of 0.1-70/~M.  The nonstimula- 
tory analogue Ql10 shows no stimulation even at the 70-#M peptide con- 
centration. The original peptides, 110-121 and 105-116, are shown as posi- 
tive and negative controls. 
function  of binding of various peptides to the MHC  I-A  a. 
Thus,  loss of K-102  in  103-114-[G108]  results in  a  sizable 
reduction of TCK activation by 103-114-[G108]  (Fig. 3, middle 
panel),  even  though  it shows  good binding  to I-A  a  (Table 
1 B).  Two stimulatory peaks can also be defined within the 
P-113 mutant  at frames  103-114 and 108-117  (Fig. 3, bottom 
panel). Importantly, the dose response of all peptides shown 
in Fig. 4  over a  large range of concentrations  (0.1-70  #M) 
showed the same bimodal response at all the stimulatory doses 
(data not shown). To summarize, there are four distinct pep- 
tide structures that are stimulatory to this single T  cell clone 
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Figure 3.  Two peak stimulatory sites occur within the three stimula- 
tory mutant peptides of 105-116. Response of CJM4-16-4 is shown to a 
series of 12-mer peptides, sequentially traversing the peptide from its NH2 
to its COOH terminus and spanning residues 100-118 (native sequence: 
PIKYLEFISEAIIHVLHSK) for the mutant peptides 105-116-[G107] (top 
panel) and 105-116-[G108] (middle  panel) and 102-120 (native  sequence: 
KYLEFISEAIIHVLHSRHP) for the mutant peptide 105-116-[Pl13] (bottom 
panel). One representative  of three experiments is shown at the optimal 
dose of 7 #M for each peptide. Activation of CJM4-16-4  is represented 
as the mean _+ SE of triplicate cultures. The mean +  SE values from tripli- 
cate cultures for the medium control, peptide 105-116 and SWM peptide 
110-121 in this experiment were 8.9  _+ 0.69 (x10-3), 3.5  _+ 0.63 (xl0 -3) 
and 58.2  _+  0.86  x  (10-3), respectively. The mean value of each peak 
was compared with the nearest lowest mean value in the preceding trough 
by the Student's t test (one tail). For example, the means at the first and 
the second peaks obtained with peptides 102-113-[G107] and 105-116-[G107], 
respectively, were compared with the means obtained with peptides 100- 
111-[G107] and 11M-115-[G107], respectively. P values for each of the peaks 
were: (a) for the G-107 mutants, <0.005; (b) for the G-108 mutants, <0.005 
and <0.025;  and (c) for the P-113 mutants, <0.05 and <0.005. 
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Figure 5.  K at position 102 is required for the core 102-113-[G108] to 
stimulate T hybrid CJM4-16. Shown is the stimulation ofT hybrid CJM4- 
16-4 with the stimulatory mutant peptide 102-113-[G108]  (@) and its variant 
in which K-102 has been replaced with A-102 (O). The response of the 
T hybrid was assayed  as described  in Fig. 1. K-102  is not required for binding 
to MHC I-A  d (see Table 1). 
Figure 4.  The "minimal core" of a peptide determinant is defined as 
the minimal residues required for both binding to MHC molecules and 
interacting with the TCR molecule (11). As an example, 108-117-[Pl13] 
is depicted above as one of the minimal cores in the stimulatory peptide 
105-117-[Pl13] because loss of residue 108 at the NH2 terminus (109-120- 
[Pl13]) and the loss of residue 117 at the COOH terminus (105-116-[Pl13]) 
(see Fig. 3) results in a considerable  loss of activation of the T hybrid CJM4- 
16. * The residues underlined represent the minimal core residues in each 
of the minimal stimulatory peptides. 
(see Fig. 4):  NH2-terminal cores (a) 102-113 with G at 107 
or 108, (b) 103-114 with P at 113; and COOH-terminal cores 
(c) 105-116-[GlO7/G108]  and (d) 108-117-[Pl13].  It should 
be pointed out that each of these structures is different from 
the core structure in the native core sequence 110-118 (Fig. 4). 
We predicted residue K-102  of the core 102-113-[G108] 
(Fig.  4) to be a TCR contact residue of the core 102-113- 
[G108] since the COOH-terminal positively charged residue 
R-118 was the TCR-interacting for the core 110-118. It is 
clear from Table  1 B that K-102 is not required for MHC 
binding. Substitution of K-102 with A-102 results in com- 
plete loss of the ability of the variant peptide 102-113-[G108] 
to activate the T hybrid CJM4-16 (Fig. 5). Thus, we propose 
that the NH2-terminal positive charge at K102 is important 
for stimulation of T hybrid CJM4-16 by core 102-113-[G108]. 
Discussion 
The current report shows that a single TCR molecule can 
be stimulated by at least five essentially "different" peptides, 
each with a distinct core structure, in the context of the same 
MHC molecule. It demonstrates that single amino acid al- 
terations of a nonstimulatory I-Ad-binding peptide can gen- 
erate stimulator), peptides for the I-Aa-restricted T hybrids 
such as CJM4-16-4.  Furthermore, we demonstrate that the 
region  100-121 of SWM binds  the MHC  I-A  a in  several 
different registers; one register, 110-121, which was used as 
the immunogen, is stimulatory, but the other registers, 105- 
116 or 102-113, are nonstimulatory. However, several mu- 
tants of 105-116 and 102-113 are able to stimulate the CJM4- 
16-4 T cell; these stimulatory mutant peptides, despite sharing 
three residues with peptide  110-121, seem essentially very 
different in charge and hydrophobicity distribution. 
Are the shared Ala-Ile-Ile residues (110A-1111-112I, [A-I- 
I]) in the five peptide cores depicted in Fig. 5 responsible for 
stimulation of CJM4-16-4? These residues are placed at the 
(a)  NH2  terminus in the peptide core 110-118, (b) at  the 
COOH terminus in cores 102-113-[G108] and 103-114-[Pl13], 
and (c) in the middle of the 12-met 105-116-[G108] and 105- 
117-[Pl13].  Thus,  if the residues A-I-I are responsible for 
triggering the TCR of CJM4-16-4, models of TCR-peptide- 
MHC interactions will have to account for their relative posi- 
tioning in different peptides (discussed below). 
The crystal structures of the class II molecule and several 
peptide-MHC class I molecules clearly show that (a) the pep- 
tide is lodged in a groovelike site on the MHC molecules, 
where the walls of the groove are formed by two ol helices 
and the floor by the 3-pleated sheets encoded by the MHC 
molecule; and (b) the orientation of the peptide in this groove 
is fixed and thus the NH2 terminus of all peptides interacts 
with one end and the COOH terminus with the other end 
of the groove (14-16).  However, what can be said about the 
orientation of the TCR molecule interacting with its ligand, 
the peptide-MHC complex? It was recently reported that 
the TCR is oriented over the peptide-MHC complex in such 
a way that the TCK c~ chain contacts the ol helix formed 
by the 3 chain of the class II molecule and the TCR ~ chain 
contacts the class II ol chain (4). In a different system, using 
mutants of MHC and TCR molecules, a reverse orientation 
of the TCR was reported earlier by Janeway and colleagues 
(17) with the TCR o~ chain contacting the class II c~ chain. 
Each of these experiments implies that a given TCK interacts 
with its peptide-MHC ligand in only a single orientation, 
albeit opposite. 
It was recently shown that alteration of a single-charged 
residue elicited a TCR with a complementary alteration in 
charge in a specific residue within the CDR3 region (4). These 
elegant experiments made two important points:  (a) there 
is relevant and direct contact between the nominal peptide 
and the CDR3 region of the TCR molecule (4, 18); and (b) 
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residues of the TCK and the peptide is important and of much 
greater significance than TCK-MHC interaction, which is 
less demanding (4,  19). 
Since the interaction of the TCR with its ligand(s) involves 
hydrophobic and/or H bond interactions with the side chains 
of the peptide residues and/or salt bridges between residues 
with opposite charges on the peptide and the TCR, respec- 
tively (1, 4), a consideration of the sequences of the different 
core peptides shown in Fig. 4 suggests the following non- 
mutually exclusive  possibilities: 
Recognition by a Single TCR Through Multiple Sets of Contact 
Residues 
(a) The strongly charged residues within the stimulatory 
sequences are not only qualitatively and quantitatively different, 
but also occupy different positions relative to the COOH 
or the NH2 terminus (Fig. 4). Thus, the peptides 103-114- 
[Pl13],  105-116-[GlO7/G108], and 108-117-[Pl13]  have no 
strongly positive charged residue, but rather one to two nega- 
tively charged residues, whereas the original peptide 110-121 
(and its 110-118 core) had the strongly basic arginine at 118 
and no negatively charged residue. If formation of a salt bridge 
involving a strongly basic residue on the peptide were essen- 
tial for TCR interaction with its ligand, it is clear that each 
of the four peptide sequences could form a salt bridge only 
at unique positions  along the TCR molecule. 
(b) Likewise, since proline at residue 113, replacing histi- 
dine, is a residue that causes a change in direction of a pep- 
tide sequence (20),  the COOH-terminal VLH sequence in 
G-107/108 mutants and in the P-113 mutant (of peptide 105- 
116, Fig. 5) might occupy a different position and thus pos- 
sibly contact different residue(s) in the TCR molecule. 
(c) A third possibility has been postulated earlier (21), that 
each of the peptides is able to stimulate the TCR by virtue 
of its ability to somehow adopt a configuration within the 
MHC binding site that is equivalent in its constellations of 
charge, hydrophobicity, and shape (the "equivalence" or mim- 
icry hypothesis). Although it cannot be ruled out, the phys- 
ical and chemical topography of amino acid residues in these 
varied peptides do not  seem to favor this possibility.  The 
stimulatory peptides  have qualitatively and  quantitatively 
different charges, as well as completely different positions of 
hydrophobic centers (as discussed above). 
It has recently been shown that individual T  cell clones 
are able to express  two functional TCR ol chains (22).  We 
have cloned and sequenced the oe and 3  chains of T  hybrid 
CJM4-16 by the PCR.  Our results show the expression of 
a single c~ chain in clone CJM4-16 (Nanda, N. K., R. Fair- 
hurst,  and E.  Sercarz, unpublished data),  thus confirming 
that it is a single TCR that shows stimulation with a diverse 
set of peptides in the context of the same MHC molecule. 
A  Single TCR May be Able to Use Two Opposite Orientations 
to Recognize its Ligands 
(a) The positively charged, carboxy-terminal K-118 in pep- 
tide 110-121 has been shown earlier by us to participate in 
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interacting with the TCR of CJM4-16 (11). In this report, 
we show that the NH2-terminal K-102 in 102-113-[G108] 
is not required for binding to MHC (Table 1 B), but is im- 
portant for triggering the TCR molecule (Fig. 5). If, as sug- 
gested by Brown et al.  (15) and Davis and Chien (23),  the 
peptide does not switch orientation in the groove of the class 
II molecule, R-118 (COOH-terminus in core 110-118) and 
K-102 (NH2 terminus in core 102-113-[G108])  could play a 
role in TCR-ligand interaction with the same specific nega- 
tively charged residue on the TCR only if the TCR switches 
its orientation by 180 ~  . This interpretation is supported by 
the fact that only a single negatively charged residue appears 
in the o~ and ~ sequences of the CDK3 regions of the CJM4- 
16-4 TCR (Nanda, N. K., K. Fairhurst, and E. Sercarz, un- 
published data).  However, it is relevant to note that there 
are other stimulatory peptides (e.g., 103-114-[Pl13]),  which 
have no positive charge, indicating that this is not a sine qua 
non for reactivity (see below). 
(b) Likewise, peptide 110-121 possesses a highly hydrophobic 
sequence A-I-I at its NH2 terminus and two of these hydro- 
phobic residues, 110-A and 111-I in peptide 110-121, have been 
shown previously by us to be important for interaction with 
the TCR of CJM4-16  (11). The identical hydrophobic se- 
quence in the stimulatory peptide, 102-113-[GlO7/G108] (and 
103-114-[Pl13]),  is situated at or near the COOH terminus. 
Thus, important hydrophobic interactions among the TCR 
and A-110 and 1-111 in peptides 110-121 and 102-113-[G107/ 
G108],  103-114-[Pl13]  are possible only if the TCR docks 
onto the peptide-MHC ligand in one orientation in the first 
case and in the opposite orientation (180  ~ shift) in the second 
case (of 102-113-[G107/G108]  and 103-114-[Pl13]).  In this 
regard, it is noteworthy that when the sequences of c~ and 
/~  chains  of the  I-A  d molecule are compared,  a  few up- 
pointing residues (24) were found to be not only comparable 
in the antiparallel ol and 3  chains of I-A  a, but also seemed 
to be symmetrically opposed, per the class II structure de- 
scribed recently (15). These residues are 79-G,  76-H, 72-A, 
and 69-Q in the oe chain and 85-G,  81-H,  73-A, and 82-N 
in the B chain. Although the residue numbers are different, 
the relative position along the helices are equivalent. That 
a single TCR can interact with the same MHC in a variety 
of ways has also been suggested in a recent report (19). 
In conclusion, our experiments reveal that, notwithstanding 
the general rule of exquisite antigen specificity of a TCR, 
the CJM4-16 TCR can be triggered by at least five different 
peptides in the context of the same MHC molecule. That 
TCR recognition as a rule may exhibit multispecificity is not 
only supported by the multispecificity exhibited by CJM4- 
16-4, but also by a previous report showing recognition of 
two different peptides by a T cell clone (25). It is of interest 
to note that in the latter case, at least one positively charged 
residue was critical for the ability of each peptide to stimu- 
late the same TCR. Recognition of allogeneic MHC mole- 
cules by a single T cell clone specific for a nominal antigen 
is another example showing the potential multispecificity of 
a TCR molecule (26-29). 
To summarize, our results, reminiscent of polyfunctional 
Igs, where a single immunoglobulin could bind several struc- turally different haptens at different subsites within the antigen- 
combining site of the antibody molecule (30), suggest that 
the TCR may have a similar multisite  structure capable of 
being  stimulated by a variety of peptides  associated with  a 
given MHC. 
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